Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Boehringer Ingelheim Pharmaceuticals, Inc. recalls Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.
Products
  • Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets)
Company
Boehringer Ingelheim Pharmaceuticals, Inc.
Where it was sold

OH

States: Ohio

Units affected
560 bottles
About this recall
Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 00597-0300-45